dc.contributor.author | Odabashian, M | en_US |
dc.contributor.author | Carlotti, E | en_US |
dc.contributor.author | Araf, S | en_US |
dc.contributor.author | Okosun, J | en_US |
dc.contributor.author | Forconi, F | en_US |
dc.contributor.author | Stevenson, FK | en_US |
dc.contributor.author | Gribben, JG | en_US |
dc.contributor.author | Calaminici, M | en_US |
dc.contributor.author | Krysov, S | en_US |
dc.date.accessioned | 2020-09-08T14:50:51Z | |
dc.date.available | 2018-09-01 | en_US |
dc.date.issued | 2018-11-29 | en_US |
dc.identifier.issn | 0006-4971 | en_US |
dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/66877 | |
dc.title | Immunoglobulin Variable Region Gene Sequences Reveal N-Glycosylation Motifs As an Early and Stable Event in Follicular Lymphoma Pathology | en_US |
dc.type | Conference Proceeding | |
dc.identifier.doi | 10.1182/blood-2018-99-112397 | en_US |
pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000454842803137&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 132 | en_US |
qmul.funder | A novel B-cell receptor-nuclear repressor ZEB2 axis that defines the clinical outcome in chronic lymphocytic leukaemia::Leuka | en_US |
qmul.funder | A novel B-cell receptor-nuclear repressor ZEB2 axis that defines the clinical outcome in chronic lymphocytic leukaemia::Leuka | en_US |